[1]
|
Agius A, Sultana R, Camenzuli C, et al. An update on the genetics of pre-eclampsia[J]. Minerva Ginecol, 2018, 70: 465-479. |
[2]
|
Anon. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia[J]. Obstet Gynecol, 2019, 133: 1. |
[3]
|
孙芳璨, 韩冰. 妊娠期高血压疾病不良结局预测模型的研究进展[J]. 实用妇产科杂志, 2019, 35: 677-681. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201909013.htm
Sun FC, Han B. Advances in research on predictive models of adverse outcomes of pregnancy-induced hypertension[J]. Shiyong Fuchanke Zazhi, 2019, 35: 677-681. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201909013.htm |
[4]
|
Tan J, Qi Y, Liu C, et al. The use of rigorous methods was strongly warranted among prognostic prediction models for obstetric care[J]. J Clin Epidemiol, 2019, 115: 98-105. doi: 10.1016/j.jclinepi.2019.07.009 |
[5]
|
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55: 227-238. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201510002.htm
Hypertensive Disorders in Pregnancy Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China(2020)[J]. Zhonghua Fuchanke Zazhi, 2020, 55: 227-238. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201510002.htm |
[6]
|
Chan P, Brown M, Simpson JM, et al. Proteinuria in preec-lampsia: how much matters?[J]. Bjog, 2005, 112: 280-285. doi: 10.1111/j.1471-0528.2004.00395.x |
[7]
|
Millman AL, Payne B, Qu Z, et al. Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia[J]. J Obstet Gynaecol Can, 2011, 33: 705-714. doi: 10.1016/S1701-2163(16)34955-6 |
[8]
|
von Dadelszen P, Payne B, Li J, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model[J]. Lancet, 2011, 377: 219-227. doi: 10.1016/S0140-6736(10)61351-7 |
[9]
|
Payne BA, Hutcheon JA, Ansermino JM, et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS(Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study[J]. PLoS Med, 2014, 11: e1001589. doi: 10.1371/journal.pmed.1001589 |
[10]
|
Payne BA, Hutcheon JA, Dunsmuir D, et al. Assessing the incremental value of blood oxygen saturation(SpO2) in the miniPIERS(Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model[J]. J Obstet Gynaecol Can, 2015, 37: 16-24. doi: 10.1016/S1701-2163(15)30358-3 |
[11]
|
Zwertbroek EF, Broekhuijsen K, Langenveld J, et al. Prediction of progression to severe disease in women with late preterm hypertensive disorders of pregnancy[J]. Acta Obstet Gynecol Scand, 2017, 96: 96-105. doi: 10.1111/aogs.13051 |
[12]
|
Thangaratinam S, Allotey J, Marlin N, et al. Prediction of complications in early-onset pre-eclampsia(PREP): development and external multinational validation of prognostic models[J]. BMC Med, 2017, 15: 68. doi: 10.1186/s12916-017-0827-3 |
[13]
|
廖媛, 刘兴会, 谭婧, 等. 建立子痫前期不良结局风险预警模型的初步研究[J]. 四川大学学报(医学版), 2018, 49: 797-802. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201805023.htm
Liao Y, Liu XH, Tan J, et al. Development of a predictive model for adverse outcomes of preeclampsia[J]. Sichuan Daxue Xuebao(Yixueban), 2018, 49: 797-802. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201805023.htm |
[14]
|
Chen R, Han Q, Zheng L, et al. Establishment and assessment of a nomogram for predicting adverse outcomes of preterm preeclampsia[J]. J Int Med Res, 2020, 48: 300060520911828. |
[15]
|
Ngwenya S, Jones B, Mwembe D, et al. Development and validation of risk prediction models for adverse maternal and neonatal outcomes in severe preeclampsia in a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe[J]. Pregnancy Hypertens, 2020, 23: 18-26. |
[16]
|
Tan J, Yang M, Liao Y, et al. Development and validation of a prediction model on severe maternal outcomes among pregnant women with pre-eclampsia: a 10-year cohort study[J]. Sci Rep, 2020, 10: 15590. doi: 10.1038/s41598-020-72527-0 |
[17]
|
马国珺, 庄旭, 邓东锐, 等. 重度子痫前期患者脏器损伤与不良妊娠结局相关性的多中心研究[J]. 实用妇产科杂志, 2020, 36: 443-447. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ202006016.htm
Ma GJ, Zhuang X, Deng DR, et al. The Correlation between Organ Function Impairment and Adverse Pregnancy Outcome in Patients with Severe Preeclampsia: a Multicenter Study[J]. Shiyong Fuchanke Zazhi, 2020, 36: 443-447. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ202006016.htm |
[18]
|
Ukah UV, Payne BA, Hutcheon JA, et al. Placental growth factor for the prognosis of women with preeclampsia(fullPIERS model extension): context matters[J]. BMC Pregnancy Childbirth, 2020, 20: 668. doi: 10.1186/s12884-020-03332-w |
[19]
|
Saleh L, Alblas MM, Nieboer D, et al. Prediction of pre-eclampsia-related complications in women with suspected or confirmed pre-eclampsia: development and internal validation of clinical prediction model[J]. Ultrasound Obstet Gynecol, 2021, 58: 698-704. doi: 10.1002/uog.23142 |
[20]
|
沈敏红, 韩冰. fullPIERS预测模型用于574例妊娠高血压人群的初探[J]. 现代妇产科进展, 2012, 21: 172-174, 178. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201203004.htm
Shen MH, Han B. A preliminary study by using fulIPIERS model in adverse outcome prediction in 574 patients of pregnancy induced hypertension in China[J]. Xiandai Fuchanke Jinzhan, 2012, 21: 172-174, 178. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201203004.htm |
[21]
|
Heestermans T, Payne B, Kayode GA, et al. Prognostic models for adverse pregnancy outcomes in low-income and middle-income countries: a systematic review[J]. BMJ Glob Health, 2019, 4: e001759. doi: 10.1136/bmjgh-2019-001759 |
[22]
|
Daru J, Zamora J, Fernández-Félix BM, et al. Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: a multilevel analysis[J]. Lancet Glob Health, 2018, 6: e548-e554. |
[23]
|
Chappell LC, Brocklehurst P, Green ME, et al. Planned early delivery or expectant management for late preterm pre-eclampsia(PHOENIX): a randomised controlled trial[J]. Lancet, 2019, 394: 1181-1190. |
[24]
|
Sinkey RG, Battarbee AN, Bello NA, et al. Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines[J]. Curr Hypertens Rep, 2020, 22: 66. |
[25]
|
Scott G, Gillon TE, Pels A, et al. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension[J]. Am J Obstet Gynecol, 2022, 226: S1222-S1236. |
[26]
|
Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction[J]. Am J Obstet Gynecol, 2022, 226: S1071-S1097. e2. |
[27]
|
Lim S, Li W, Kemper J, et al. Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia: A Systematic Review and Meta-analysis[J]. Obstet Gynecol, 2021, 137: 72-81. |